Records containing: Metastatic Osteosarcoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-21
Phase I/II Study of Aerosol Interleukin-2 for Pulmonary Metastases
CLINICAL_TRIALS study record update · 2026-04-17
A Phase 2 Trial of Atezolizumab and Cabozantinib in Adolescents and Young Adults With Recurrent/Metastatic Osteosarcoma (TACOS)
CLINICAL_TRIALS study record update · 2026-04-15
A Feasibility and Randomized Phase 2/3 Study of the VEGFR2/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma
CLINICAL_TRIALS study record update · 2026-04-15
A Phase II Multi-Arm Study to Test the Efficacy of Oleclumab and Durvalumab in Multiple Sarcoma Subtypes
CLINICAL_TRIALS study record update · 2026-02-27
A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2023-08-14
An Open Label, Single Centre, Single Arm, Prospective Feasibility Study Evaluating the Effectiveness of Near-infrared Fluorescence (NIRF) Using Indo-cyanine Green (ICG) in Minimally Invasive Paediatric Oncology Surgery (MIS)
CLINICAL_TRIALS study record update · 2023-06-07
A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-operative Chemotherapy
CLINICAL_TRIALS study record update · 2022-03-28
Therapeutically Applicable Research to Generate Effective Treatments (TARGET) for Osteosarcoma
CLINICAL_TRIALS study record update · 2021-05-07
A Phase 2 Study of Human-Mouse Chimeric Anti-disialoganglioside Monoclonal Antibody ch14.18 (Dinutuximab, NSC# 764038) in Combination With Sargramostim (GM-CSF) in Patients With Recurrent Osteosarcoma
CLINICAL_TRIALS study record update · 2021-04-13
A Phase II Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung
CLINICAL_TRIALS study record update · 2021-02-21
Phase 2 Study of Denosumab (NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma
CLINICAL_TRIALS study record update · 2020-09-04
A Phase 2 Study of XL184 (Cabozantinib) in Treating Patients With Relapsed Osteosarcomas and Ewing Sarcomas
CLINICAL_TRIALS study record update · 2020-08-10
A Phase II Study of Pazopanib With Oral Topotecan in Patients With Metastatic and Non-resectable Soft Tissue and Bone Sarcomas
CLINICAL_TRIALS study record update · 2019-10-29
Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
CLINICAL_TRIALS study record update · 2016-07-22
A Phase 1B/II Study of GDC-0449 (NSC 747691) in Combination With RO4929097, a Gamma-Secretase Inhibitor (GSI) in Advanced/Metastatic Sarcomas
CLINICAL_TRIALS study record update · 2016-05-19
Retrospective Study of Genetic Risk Factors for Osteosarcoma
CLINICAL_TRIALS study record update · 2016-05-19
Observational - Tissue Factor Expression in Bone Sarcomas
CLINICAL_TRIALS study record update · 2015-07-30
A Phase 2 Study of Temsirolimus (CCI-779, NSC 683864) and IGF-1 Receptor Antibody Cixutumumab (IMC-A12, NSC 742460) in Patients With Metastatic Sarcomas
CLINICAL_TRIALS study record update · 2015-06-17
A Phase II, Open Label, Non-randomized Study of Second or Third Line Treatment With the Combination of Sorafenib and Everolimus in Patients Affected by Relapsed and Non-resectable High-grade Osteosarcoma
CLINICAL_TRIALS study record update · 2015-05-12
Observational - Methylation Status as Predictor of Response to Neoadjuvant Chemotherapy in Osteosarcoma
CLINICAL_TRIALS study record update · 2014-03-17
A Phase II Clinical and Correlative Study of BAY 43-9006 (Sorafenib) IND 69,896 in Sarcoma
CLINICAL_TRIALS study record update · 2014-01-30
A Phase II Clinical Trial of Angiotensin 1-7 For the Second or Third Line Treatment of Patients With Metastatic or Unresectable Sarcomas
CLINICAL_TRIALS study record update · 2013-06-04
A Multicenter Phase I Trial of 17-N-allylamino-17-demethoxy Geldanamycin (17-AAG, NSC #330507) in Patients With Recurrent/Refractory Pediatric Solid Tumors (Ewing's Sarcoma, Desmoplastic Small Round Cell Tumor, Osteosarcoma, Neuroblastoma, and Rhabdomyosarcoma) and Leukemia
CLINICAL_TRIALS study record update · 2013-02-07
A Phase I Trial of Weekly 17-Allylamino-17 Demethoxygeldanamycin
CLINICAL_TRIALS study record update · 2013-02-04
A Groupwide Phase II Study of Trastuzumab (Herceptin) in Metastatic Osteosarcoma Patients With Tumors That Overexpress HER2